Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Neutropenia and meta-analysis and UGT1A1[original query] |
|---|
| UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. Journal of the National Cancer Institute 2007 Sep 99 (17): 1290-5. Hoskins Janelle M, Goldberg Richard M, Qu Pingping, Ibrahim Joseph G, McLeod Howard |
| Dose-dependent association between UGT1A1*28 genotype and irinotecan-induced neutropenia: low doses also increase risk. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Aug 16 (15): 3832-42. Hu Zhe-Yi, Yu Qi, Pei Qi, Guo Che |
| Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis. Pharmacogenomics 2012 Jun 13 (8): 889-99. Dias Mafalda M, McKinnon Ross A, Sorich Michael |
| Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. The pharmacogenomics journal 2014 Apr 14 (2): 120-9. Liu X, Cheng D, Kuang Q, Liu G, Xu |
| The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 Feb 19 (1): 56-62. Chen Yi-Jing, Hu Fei, Li Chun-Yan, Fang Jue-Min, Chu Li, Zhang Xi, Xu Qi |
| UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer chemotherapy and pharmacology 2014 Mar 73 (3): 551-60. Cheng Lei, Li Ming, Hu Jing, Ren Wei, Xie Li, Sun Zhan-Peng, Liu Bao-Rui, Xu Gen-Xing, Dong Xiao-Liang, Qian Xiao-Pi |
| UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer chemotherapy and pharmacology 2017 Jun . Zhang Xue, Yin Jia-Fu, Zhang Jiao, Kong Shu-Jia, Zhang Hong-Yin, Chen Xue-M |
| UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis. Cancer chemotherapy and pharmacology 2017 Jun 79 (6): 1109-1117. Chen Xuewei, Liu Liping, Guo Zhihua, Liang Wenhua, He Jiaxi, Huang Liyan, Deng Qiuhua, Tang Hailing, Pan Hui, Guo Minzhang, Liu Yang, He Qihua, He Jianxi |
| Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy. Journal of Cancer 2017 8 (4): 691-703. Liu Xing-Han, Lu Jun, Duan Wei, Dai Zhi-Ming, Wang Meng, Lin Shuai, Yang Peng-Tao, Tian Tian, Liu Kang, Zhu Yu-Yao, Zheng Yi, Sheng Qian-Wen, Dai Zhi-J |
| UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis. Asia-Pacific journal of clinical oncology 2018 Jun . Yang Yuwei, Zhou MengMeng, Hu Mingjun, Cui Yanjie, Zhong Qi, Liang Ling, Huang F |
| Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis. Bioscience reports 2020 Sep . Zhu Xiaoyun, Ma Ruchao, Ma Xin, Yang Ga |
| Efficacy and safety of sacituzumab govitecan Trop-2-targeted antibody-drug conjugate in solid tumors and UGT1A1*28 polymorphism: a systematic review and meta-analysis. BJC reports 2024 11 2 (1): 85. Rehena Sultana, Sylvia Chen, Elaine Hsuen Lim, Rebecca Dent, Balram Chowb |
- Page last reviewed:Feb 1, 2024
- Content source: